This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 7 EPO patents. Top assignees: Les Laboratoires Servier, Shanghai Institute of Pharmaceutical Industry, Vernalis &r&d) Ltd.. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 296 
2 out of 42 
1 out of 68 
Years Active: 2014-2024
Title: The Innovative Achievements of Inventor Michael Lynch
Introduction
Michael Lynch, a prominent inventor based in Saint Jean de la Ruelle, France, has made significant contributions to the field of pharmaceutical sciences. With a total of five patents to his name, his innovations focus primarily on treatments for cardiovascular diseases, aiming to improve patient outcomes through advanced medicinal products.
Latest Patents
Among his latest patents are groundbreaking developments in the area of myocardial ischemia. These include crystalline forms of a MCL-1 inhibitor, alongside the processes for their preparation and pharmaceutical compositions containing them. Additionally, he has patented crystalline forms of Compound A, which is a salt of ivabradine, and elucidated the process for its preparation. Another notable invention is the ivabradine hemipamoate of formula (I) and its hydrates, which are designed for use in treating various clinical conditions such as angina pectoris, myocardial infarction, and rhythm disturbances associated with heart failure.
Career Highlights
Michael has worked with leading companies in the pharmaceutical industry, including Les Laboratoires Servier and the Shanghai Institute of Pharmaceutical Industry. His role in these organizations has been pivotal in advancing research and development in heart-related therapeutics.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues such as Philippe Letellier and Hanbin Shan. These partnerships have fostered innovation and propelled the development of new medicinal products aimed at addressing significant health challenges.
Conclusion
Michael Lynch's dedication to advancing medical science through his patents reflects his status as an influential inventor in the field. By focusing on critical areas of cardiovascular health, he has made lasting contributions that have the potential to save lives and improve the quality of life for many patients around the world. His ongoing work continues to inspire future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile